You were just told you have ‘elevated’ amyloid. How do you respond?
Newly published research in PLOS ONE from the Penn Program on Precision Medicine for the Brain reveals what research participants thought, felt, and did after learning they have “elevated” amyloid, a biomarker of Alzheimer’s disease.
FULL STORY AT Penn Memory Center →